drugset / Trial / NCT00352261
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to compare the treatment of esomeprazole 40 mg once daily and lansoprazole 30 mg once daily in controlling intragastric pH in Barrett's Esophagus patients
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 40 mg | — |
| Subject | Lansoprazole | Other / unclassified | 30 mg | — |